Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients.
about
Oral morphine for cancer painOxycodone for cancer-related painImpact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer painOral morphine for cancer painOral morphine for cancer painOxycodone controlled release in cancer pain managementOxycodone combinations for pain relief.Recent advances in the use of opioids for cancer painOpioid rotation versus combination for cancer patients with chronic uncontrolled pain: a randomized study.Preclinical pharmacology and opioid combinations.Highlights in opioid agonists and antagonists.Controlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic review.Opioid conversions in acute care.A phase 3, randomized, double-blind comparison of analgesic efficacy and tolerability of Q8003 vs oxycodone or morphine for moderate-to-severe postoperative pain following bunionectomy surgery.Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project.A systematic review of oxycodone in the management of cancer pain.Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review.A systematic review of combination step III opioid therapy in cancer pain: an EPCRC opioid guideline project.Efficacy and safety of dual-opioid therapy in acute pain.Evidence from basic research for opioid combinations.Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations.Oxycodone for cancer-related pain.Pharmacological Management of Cancer-Related Pain.Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease.Assessing the response to opioids in cancer patients: a methodological proposal and the results.Effect of pH on sublingual absorption of oxycodone hydrochloride.Inconsistencies in opioid equianalgesic ratios: clinical and research implications.Ventilatory responses of healthy subjects to intravenous combinations of morphine and oxycodone under imposed hypercapnic and hypoxaemic conditionsCo-administration of oxycodone and morphine and analgesic synergy re-examined.Opioid combination for cancer pain.Efficacy and safety of dual opioid therapy.An exploratory analysis on the effectiveness of four strong opioids in patients with cancer pain.Response to Smith MT and de la Iglesia FA: ‘Coadministration of oxycodone and morphine and analgesic synergy re-examined.’.
P2860
Q24185873-8D8B4123-36ED-4B81-A1FB-292F058392F9Q24187917-EE680827-5F52-45D0-94F8-8EE13F2A5FADQ24194524-CBA9E2C9-3F19-47C0-BD58-37033B1E22E8Q24201079-D002F173-2A78-4EA2-BC2D-BA3122536880Q24243158-314116FA-E680-43EC-AA09-D0AF4EEF7692Q24683073-5E28AD85-5421-4FD1-A315-13C46B2FA94EQ33713626-37D1CA2F-A547-4FB6-9493-03B74E324090Q34418203-7F52A6B8-590C-47B1-9675-58A2175A9EC6Q35777999-7A897A49-E9C0-4182-84C6-3AF9717E0DBAQ35839130-2DA2CD15-7757-475B-8130-1EFD7C805889Q36453307-DE79962C-38C7-4721-A635-0875D8732161Q36480717-2644E7D1-C775-4DA9-A58A-56BE7EF28E7CQ36735197-6B1B9E9F-08B3-4FD0-8393-CA8164BDE7DCQ37279783-78C61EDC-2A9C-4A0B-BA2F-62BE404D5228Q37894984-2EA00DA5-5C39-4CD8-A321-EA74CFC82386Q37894992-8A7CDE5E-E08D-4CBE-98DA-2EBC2F900530Q37894998-E1F661A2-0AB2-4EF3-90B3-430EAFB2D693Q37895006-6AA3C0DD-1A8C-4439-8250-FF4E355BF776Q37993911-E1C9AE0C-0F4C-4290-BFFD-87011630FBB7Q37999097-D036B2FF-E63C-489D-8B18-B7E06F7E2C8DQ38124029-D4354CF3-C6A1-4B05-9D88-2856DA476FB3Q38614104-97C1FDD8-0145-4F31-A411-075146CD7C11Q38672359-87CA5E94-AB89-44AE-BE10-FFA1F1899F8AQ38824938-1B0C7412-A1DC-46D4-B17C-906F8504C16CQ39197627-C12FF2AB-1AD9-4D12-B38E-699EA79668DBQ41981062-317F57CF-4A84-4C98-B631-0ED33BE1BA68Q42726789-69FEAF26-E34F-43A6-B604-B7DC9D42D2C3Q42758851-E365DC04-8C97-491A-8D53-5997A8E428B0Q42758974-895F7815-F7AE-4EFA-86CE-8F93FCC43EC6Q43248657-581654C8-9DCE-4AEB-86DC-5F2740266AACQ44347360-80814E2F-D3FE-4B5A-9B3A-45778FD3029BQ45832293-765AA204-F6DB-4AE6-A713-A9879D4A04E5Q46152830-C34C46D7-0047-4C78-8474-433492BCFA2C
P2860
Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Comparison of sustained-releas ...... e in advanced cancer patients.
@ast
Comparison of sustained-releas ...... e in advanced cancer patients.
@en
type
label
Comparison of sustained-releas ...... e in advanced cancer patients.
@ast
Comparison of sustained-releas ...... e in advanced cancer patients.
@en
prefLabel
Comparison of sustained-releas ...... e in advanced cancer patients.
@ast
Comparison of sustained-releas ...... e in advanced cancer patients.
@en
P2093
P2860
P356
P1476
Comparison of sustained-releas ...... e in advanced cancer patients.
@en
P2093
G M Oliveira
G R Lauretti
N L Pereira
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601365
P407
P577
2003-12-01T00:00:00Z